Safety and efficacy of apatinib in patients with advanced gastric or gastroesophageal junction adenocarcinoma after the failure of two or more lines of chemotherapy (AHEAD): a prospective, single-arm, multicenter, phase IV study

Peer Review reports

Original Submission
20 Sep 2022	Submitted	Original manuscript
13 Oct 2022	Reviewed	Reviewer Report - Ashish Manne
17 Nov 2022	Reviewed	Reviewer Report
12 Dec 2022	Author responded	Author comments - Jin Li
Resubmission - Version 2
12 Dec 2022	Submitted	Manuscript version 2
29 Dec 2022	Reviewed	Reviewer Report
26 Feb 2023	Author responded	Author comments - Jin Li
Resubmission - Version 3
26 Feb 2023	Submitted	Manuscript version 3
14 Mar 2023	Author responded	Author comments - Jin Li
Resubmission - Version 4
14 Mar 2023	Submitted	Manuscript version 4
Publishing
20 Mar 2023	Editorially accepted
5 May 2023	Article published	10.1186/s12916-023-02841-7

Back to article page